{"transactions":[{"id":907739,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":26679,"price":46.75,"value":1247243.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":147282,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":907738,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11861,"price":46.75,"value":554501.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":173961,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":907737,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":32734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,734 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":185822,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":907736,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":26421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":153088,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":1004981,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T16:23:09.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":4858,"price":41.2756,"value":200516.8648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.00 to $41.75, inclusive."}],"balance_after":126667,"source":{"system":"sec-edgar","filing":"0001862082-25-000004","document":"form4-11072025_091106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208225000004/form4-11072025_091106.xml","form_type":"4"}},{"id":1004980,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T16:23:09.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":25142,"price":40.3801,"value":1015236.4742,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":131525,"source":{"system":"sec-edgar","filing":"0001862082-25-000004","document":"form4-11072025_091106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208225000004/form4-11072025_091106.xml","form_type":"4"}},{"id":1193626,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T17:06:10.000Z","date":"2025-03-21","kind":"sale","planned":true,"acquired":false,"shares":6396,"price":30.0295,"value":192068.682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive."}],"balance_after":156667,"source":{"system":"sec-edgar","filing":"0001062993-25-006149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325006149/form4.xml","form_type":"4"}},{"id":1193625,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T17:06:10.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":1206,"price":30.0011,"value":36181.3266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":163063,"source":{"system":"sec-edgar","filing":"0001062993-25-006149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325006149/form4.xml","form_type":"4"}},{"id":1200298,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T17:35:14.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":977,"price":30.0034,"value":29313.3218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":164269,"source":{"system":"sec-edgar","filing":"0001062993-25-005753","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005753/form4.xml","form_type":"4"}},{"id":1207895,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-13T16:49:26.000Z","date":"2025-03-11","kind":"sale","planned":true,"acquired":false,"shares":10445,"price":30.006,"value":313412.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":165246,"source":{"system":"sec-edgar","filing":"0001062993-25-005395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005395/form4.xml","form_type":"4"}},{"id":1215247,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T16:02:15.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":1504,"price":30.0007,"value":45121.0528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":175691,"source":{"system":"sec-edgar","filing":"0001062993-25-005021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005021/form4.xml","form_type":"4"}},{"id":1215246,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T16:02:15.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":1949,"price":30,"value":58470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."}],"balance_after":177195,"source":{"system":"sec-edgar","filing":"0001062993-25-005021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005021/form4.xml","form_type":"4"}},{"id":1271893,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T16:10:05.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":22317,"price":30.52,"value":681114.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":179144,"source":{"system":"sec-edgar","filing":"0001062993-25-002178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325002178/form4.xml","form_type":"4"}},{"id":1271892,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T16:10:05.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":8109,"price":30.52,"value":247486.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":201461,"source":{"system":"sec-edgar","filing":"0001062993-25-002178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325002178/form4.xml","form_type":"4"}},{"id":1271891,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T16:10:05.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":26957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,957 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":209570,"source":{"system":"sec-edgar","filing":"0001062993-25-002178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325002178/form4.xml","form_type":"4"}},{"id":1271890,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T16:10:05.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":51768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":182613,"source":{"system":"sec-edgar","filing":"0001062993-25-002178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325002178/form4.xml","form_type":"4"}},{"id":1499299,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-29T16:29:04.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":19710,"price":34.2145,"value":674367.795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.94 to $34.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":130845,"source":{"system":"sec-edgar","filing":"0001062993-24-011413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299324011413/form4.xml","form_type":"4"}},{"id":1643433,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T16:15:34.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":9453,"price":33.7,"value":318566.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":150555,"source":{"system":"sec-edgar","filing":"0001062993-24-003170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299324003170/form4.xml","form_type":"4"}},{"id":1643432,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T16:15:34.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":16868,"price":33.7,"value":568451.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":160008,"source":{"system":"sec-edgar","filing":"0001062993-24-003170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299324003170/form4.xml","form_type":"4"}},{"id":1643431,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T16:15:34.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":30856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,856 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":176876,"source":{"system":"sec-edgar","filing":"0001062993-24-003170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299324003170/form4.xml","form_type":"4"}},{"id":1643430,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T16:15:34.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":40600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":146020,"source":{"system":"sec-edgar","filing":"0001062993-24-003170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299324003170/form4.xml","form_type":"4"}},{"id":1947449,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T16:11:14.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":31640,"price":23.7726,"value":752165.064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.47 to $24.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":105420,"source":{"system":"sec-edgar","filing":"0001062993-23-007174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299323007174/form4.xml","form_type":"4"}},{"id":2016870,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T17:17:48.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":3887,"price":26.75,"value":103977.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":137060,"source":{"system":"sec-edgar","filing":"0001062993-23-003477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299323003477/form4.xml","form_type":"4"}},{"id":2016869,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T17:17:48.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":6967,"price":26.75,"value":186367.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":140947,"source":{"system":"sec-edgar","filing":"0001062993-23-003477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299323003477/form4.xml","form_type":"4"}},{"id":2016868,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T17:17:48.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":12565,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 12,565 performance share units granted in the issuer's three prior fiscal years."}],"balance_after":147914,"source":{"system":"sec-edgar","filing":"0001062993-23-003477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299323003477/form4.xml","form_type":"4"}},{"id":2016867,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T17:17:48.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":45045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":135349,"source":{"system":"sec-edgar","filing":"0001062993-23-003477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299323003477/form4.xml","form_type":"4"}},{"id":2141410,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-06T16:23:09.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":4350,"price":17.35,"value":75472.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.25 to $17.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":90304,"source":{"system":"sec-edgar","filing":"0001062993-22-020614","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322020614/form4.xml","form_type":"4"}},{"id":2355300,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T16:13:53.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":1237,"price":17.63,"value":21808.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":94654,"source":{"system":"sec-edgar","filing":"0001062993-22-006643","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322006643/form4a.xml","form_type":"4/A","original_submission_date":"2022-02-14"}},{"id":2355299,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T16:13:53.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":2821,"price":17.63,"value":49734.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":95891,"source":{"system":"sec-edgar","filing":"0001062993-22-006643","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322006643/form4a.xml","form_type":"4/A","original_submission_date":"2022-02-14"}},{"id":2355298,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T16:13:53.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":4212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year."}],"balance_after":98712,"source":{"system":"sec-edgar","filing":"0001062993-22-006643","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322006643/form4a.xml","form_type":"4/A","original_submission_date":"2022-02-14"}},{"id":2355297,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T16:13:53.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":94500,"source":{"system":"sec-edgar","filing":"0001062993-22-006643","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322006643/form4a.xml","form_type":"4/A","original_submission_date":"2022-02-14"}},{"id":2398512,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T18:38:26.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":1237,"price":17.63,"value":21808.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":87654,"source":{"system":"sec-edgar","filing":"0001062993-22-004322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322004322/form4.xml","form_type":"4"}},{"id":2398511,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T18:38:26.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":2821,"price":17.63,"value":49734.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":88891,"source":{"system":"sec-edgar","filing":"0001062993-22-004322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322004322/form4.xml","form_type":"4"}},{"id":2398510,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T18:38:26.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":4212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year."}],"balance_after":91712,"source":{"system":"sec-edgar","filing":"0001062993-22-004322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322004322/form4.xml","form_type":"4"}},{"id":2398509,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T18:38:26.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001062993-22-004322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299322004322/form4.xml","form_type":"4"}},{"id":2699243,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-24T17:11:40.000Z","date":"2021-05-24","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":42000,"source":{"system":"sec-edgar","filing":"0001192482-21-000452","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000119248221000452/edgar.xml","form_type":"4"}}]}